These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 5795020)

  • 1. [Hepatotropic and proteo-anabolic therapeutic effects of a total hepatic preparation with a constant titer of natural coenzymatic cobalamin].
    Guidetti E; Vacha R; Vacha G
    Clin Ter; 1969 May; 49(4):323-36. PubMed ID: 5795020
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of parenteral administration of hepatotropic preparation with dynamotropic properties in patients with liver diseases].
    Rottini E; Scianaro L
    Clin Ter; 1969 Oct; 51(1):49-61. PubMed ID: 5364033
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapeutic efficiency of purified liver extract with an increased amount of vitamin B 12 in coenzymatic form in patients with liver diseases and rheumatoid arthritis].
    Guglielmi G; Garbagnati N; Iaschi P; Ciavarelli F; Ferrantelli D
    Clin Ter; 1969 Nov; 51(3):227-44. PubMed ID: 5407318
    [No Abstract]   [Full Text] [Related]  

  • 4. [Influence of treatment with nucleosides, liver extract and vitamin B 12 on various hepatic functional defects and on cellular proliferation of bone marrow in chronic liver diseases].
    Turpini R
    Clin Ter; 1970 Apr; 53(1):9-23. PubMed ID: 5472849
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapeutic effect of a preparation of total liver extract, cyanocobalamin and amino acids of the Krebs cycle, in acute and chronic liver diseases].
    Pignattari S; Sarti F; Toscano S; Dal Monte PR
    Minerva Med; 1972 Jul; 63(53):2861-72. PubMed ID: 5049878
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapeutic effectiveness of B-vitamins and other drugs in chronic liver-parenchyma diseases?].
    Wildhirt E
    Munch Med Wochenschr; 1968 Oct; 110(40):2313-4. PubMed ID: 5761605
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutic effectiveness of B-vitamins and other drugs in chronic liver-parenchyma diseases?].
    Heinrich HC
    Munch Med Wochenschr; 1968 Oct; 110(40):2311-2. PubMed ID: 5761604
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapeutic activity in the geriatric age of hepatic opotherapy in association with high doses of nucleosides].
    Baldoni E; Floris E; Serenthà P; Negri U; Nuzzo L
    G Gerontol; 1968 Nov; 16(11):1261-99. PubMed ID: 5731973
    [No Abstract]   [Full Text] [Related]  

  • 9. [Alphamercaptopropionylglycine in chronic hepatopathies].
    Cacciari G; Malaguti P; Zincati GC
    Policlinico Med; 1972; 79(3):165-73. PubMed ID: 5051108
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical test of the therapeutic effectiveness of hepatic opotherapy associated with high doses of nucleosides].
    Vercillo L; Mollica G; Florio G
    Minerva Med; 1972 Jun; 63(44):2478-85. PubMed ID: 5035396
    [No Abstract]   [Full Text] [Related]  

  • 11. [Considerations on the treatment with the combination of ribonucleosides, hepatic extract and vitamin B-12 (Nuclepatox) of acute and chronic liver diseases in the course of pulmonary tuberculosis].
    Ravazzoni C; Balzano E; Cuneo S
    Minerva Med; 1967 Jan; 58(6):141-7. PubMed ID: 6016918
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hepa-listrocol in the therapy of chronic inflammatory liver diseases].
    Baum HH
    Landarzt; 1967 Apr; 43(11):530-3. PubMed ID: 5585071
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical work on a new drug combination used in liver diseases and its consequences].
    Naufal J
    Hospital (Rio J); 1969 Apr; 75(4):1469-82. PubMed ID: 5306437
    [No Abstract]   [Full Text] [Related]  

  • 14. [Report on the experiences in the ambutant treatment of hepatopathy with Heparhormforte].
    Ignatius A
    Landarzt; 1965 Sep; 41(25):1090-2. PubMed ID: 5857646
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical research on the hepatoprotective and antianemic action of hepatic opotherapy associated with nucleosides in high doses].
    Bestagno M
    Arch Maragliano Patol Clin; 1966; 22(3):299-309. PubMed ID: 5953073
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies on the use of liver extracts enriched with uridine, cytidine and vitamin B 12 in pediatric therapy].
    Rizzo A
    Minerva Pediatr; 1971 May; 23(18):803-10. PubMed ID: 5090393
    [No Abstract]   [Full Text] [Related]  

  • 17. [The effect of a new hepatoprotective drug on bilirubinemia in geriatric age patients].
    Baldoni E; Floris E; Nuzzo L
    G Gerontol; 1968 Aug; 16(8):789-92. PubMed ID: 5740954
    [No Abstract]   [Full Text] [Related]  

  • 18. [Nucleosides in the therapy of hepatopathies].
    Urbinati GC
    Clin Ter; 1966 Oct; 39(1):39-54. PubMed ID: 5998856
    [No Abstract]   [Full Text] [Related]  

  • 19. [The behavior of the sulfobromophthalein chromoelimination curves subjects with ethylic hepatopathy treated with a liver extract enriched with nucleosides of the pyrimidine series and ith cyanocobalamine].
    D'Agostino F
    Minerva Med; 1970 Oct; 61(87):4893-901. PubMed ID: 5488540
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cholesterolemic changes after treatment with a new hepatoprotective drug in geriatric patients].
    Baldoni E; Floris E; Nuzzo L
    G Gerontol; 1968 Aug; 16(8):785-7. PubMed ID: 5740953
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.